Physician profile
Robert Wallace
NPI 1720315336
$1,191.65
in general payments reported to CMS, 2019-2025
17 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $356 · 2023: $168 · 2024: $141 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $238.82 | 2022-2025 | Ojjaara, Blenrep |
| Janssen Biotech, INC. | $184.56 | 2022-2025 | Darzalex, Rybrevant |
| Takeda Pharmaceuticals U.S.A., INC. | $124.97 | 2021 | |
| Abbvie INC. | $117.27 | 2024-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $71.18 | 2023 | Epkinly, Imbruvica |
| Taiho Oncology, INC. | $63.27 | 2021-2023 | |
| Genentech USA, INC. | $54.64 | 2023 | Phesgo, Ocrevus |
| Coherus Oncology, INC. | $53.53 | 2024-2025 | Udenyca |
| Tersera Therapeutics LLC | $45.61 | 2024-2025 | Quzyttir |
| Smith+Nephew, INC. | $44.99 | 2024 | Stravix Pl |
| Ethicon US, LLC | $37.16 | 2021 | |
| Polynovo North America LLC | $33.23 | 2022 | |
| Integra Lifesciences Corporation | $28.24 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $27.59 | 2025 | Dysport |
| Kyowa Kirin, INC. | $25.38 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $24.12 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.09 | 2023 | Kisqali |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.